➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Harvard Business School
Dow
Medtronic
Moodys

Last Updated: May 14, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CABERGOLINE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for CABERGOLINE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00033111 A Study of Cabergoline for the Treatment of Cocaine Dependence - 1 Completed University of California, Los Angeles Phase 2 2001-06-01 The purpose of this study is to assess cabergoline for the Treatment of Cocaine Dependence
NCT00033111 A Study of Cabergoline for the Treatment of Cocaine Dependence - 1 Completed National Institute on Drug Abuse (NIDA) Phase 2 2001-06-01 The purpose of this study is to assess cabergoline for the Treatment of Cocaine Dependence
NCT00129181 Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease Completed GE Healthcare N/A 2005-01-01 This study investigates whether there is a change in 123iodine-2ß- carbomethoxy-3ß-(4-iodophenyl) tropane ([123I]ß-CIT) uptake after short-term treatment with levodopa compared to either dopamine agonist or placebo.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for CABERGOLINE

Condition Name

Condition Name for CABERGOLINE
Intervention Trials
Acromegaly 5
Ovarian Hyperstimulation Syndrome 5
Infertility 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for CABERGOLINE
Intervention Trials
Ovarian Hyperstimulation Syndrome 11
Prolactinoma 6
Parkinson Disease 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for CABERGOLINE

Trials by Country

Trials by Country for CABERGOLINE
Location Trials
United States 26
Egypt 11
Italy 9
Brazil 8
Spain 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for CABERGOLINE
Location Trials
Massachusetts 3
Texas 3
Alabama 2
Illinois 2
New York 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for CABERGOLINE

Clinical Trial Phase

Clinical Trial Phase for CABERGOLINE
Clinical Trial Phase Trials
Phase 4 8
Phase 3 12
Phase 2/Phase 3 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for CABERGOLINE
Clinical Trial Phase Trials
Completed 27
Recruiting 11
Not yet recruiting 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for CABERGOLINE

Sponsor Name

Sponsor Name for CABERGOLINE
Sponsor Trials
Pfizer 6
Benha University 3
National Institute on Drug Abuse (NIDA) 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for CABERGOLINE
Sponsor Trials
Other 60
Industry 17
NIH 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
McKesson
Boehringer Ingelheim
AstraZeneca
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.